Relmada Therapeutics Confirms Conference Call for Financial Results
Relmada Therapeutics, Inc. (NASDAQ: RLMD), a pioneering biotechnology firm focused on innovative therapies for oncology and central nervous system disorders, has officially scheduled a conference call and webcast. This event will be held on an upcoming Thursday, launching at 4:30 PM ET, as they present their financial performance for the third quarter of 2025, wrapping up a period that ended on September 30, 2025. Alongside the results, the company will highlight recent advancements in its business initiatives.
Details of the Conference Call and Webcast
The specifics of the conference call are as follows:
Date and Time
Date: Thursday, November 13, 2025, at 4:30 PM ET
Participant Dial-in Information
US Participants: 1-877-407-0792
International Participants: 1-201-689-8263
How to Access the Webcast
Listeners can join the discussion via webcast through a designated link provided by the company, ensuring easy access for all participants.
Replay of the Webcast
For those unable to attend the live event, a replay will be accessible in the Investors section of Relmada’s official website, allowing stakeholders to catch up on this informative session at their convenience.
About Relmada Therapeutics, Inc.
Relmada Therapeutics is a clinical-stage biotechnology company with a commitment to developing transformative therapies targeting both oncology and central nervous system (CNS) conditions. The firm’s leading drug candidates, NDV-01 and sepranolone, are currently making promising strides through mid-stage clinical trials, aiming to fulfill significant unmet medical needs within these critical areas.
Investor and Media Contacts
For Investor Inquiries
Brian Ritchie
LifeSci Advisors
Email: britchie@lifesciadvisors.com
For Media Inquiries
Reach out to Corporate Communications at Relmada, via email at media@relmada.com for any press or media-related questions, ensuring you have the necessary support and detailed information.
Frequently Asked Questions
What is the main purpose of the upcoming conference call?
The conference call will discuss Relmada Therapeutics’ financial results for Q3 2025 and recent business progress.
When is the scheduled date and time for the call?
The call will take place on Thursday, November 13, 2025, at 4:30 PM ET.
How can I access the conference call?
You can join the conference call via dial-in or access the webcast using the link provided by the company.
Will there be a replay available after the call?
Yes, a replay of the webcast will be available in the Investors section of Relmada's website for those who miss the live event.
What are the key focuses of Relmada Therapeutics?
Relmada Therapeutics primarily focuses on developing therapies for oncology and central nervous system conditions, with promising candidates in their pipeline.